These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15255013)

  • 1. [Resection of liver metastasis of colorectal origin following chemotherapy with irinotecan].
    Adam R
    Ann Chir; 2004 Mar; 129 Spec No 2():2-4. PubMed ID: 15255013
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic artery infusion for liver metastases from colorectal cancer.
    Bonetti A
    Lancet; 2003 Feb; 361(9355):358-9. PubMed ID: 12573366
    [No Abstract]   [Full Text] [Related]  

  • 3. [Four cases of multiple liver metastasis of colorectal cancer treated with hepatic resection after chemotherapy].
    Amaya K; Nishimura G; Sasaki S; Terada I; Nishijima K; Tani T; Shimizu K; Miwa K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1768-71. PubMed ID: 11708030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement.
    Bartlett DL; Berlin J; Lauwers GY; Messersmith WA; Petrelli NJ; Venook AP
    Ann Surg Oncol; 2006 Oct; 13(10):1284-92. PubMed ID: 16955384
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome.
    Jones RP; Stättner S; Dunne DF; O'Grady E; Smethurst A; Terlizzo M; Malik HZ; Fenwick SW; Poston GJ
    Eur J Surg Oncol; 2013 Oct; 39(10):1122-8. PubMed ID: 23928482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer.
    Fuchs CS; Moore MR; Harker G; Villa L; Rinaldi D; Hecht JR
    J Clin Oncol; 2003 Mar; 21(5):807-14. PubMed ID: 12610178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.
    Small RM; Lubezky N; Shmueli E; Figer A; Aderka D; Nakache R; Klausner JM; Ben-Haim M
    J Surg Oncol; 2009 Feb; 99(2):93-8. PubMed ID: 19065637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoembolization for unresectable colorectal liver metastases with drug-eluting microspheres].
    Skupchenko AV; Lysenko AV; Korolev DG; Skobel'tsov DA; Rassudishkin AS
    Vestn Rentgenol Radiol; 2014; (6):33-8. PubMed ID: 25975131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy for liver metastasis of colorectal cancer].
    Amano M; Niinobu T; Itani Y; Nishikawa Y; Nakagawa S; Higaki N; Hayashida H; Fujita M; Sakon M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1721-3. PubMed ID: 16315920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement by Bartlett et al.
    Chari RS; Helton WS; Marsh RD
    Ann Surg Oncol; 2006 Oct; 13(10):1293-5. PubMed ID: 16952023
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
    J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of neo-adjuvant chemotherapy by FOLFOX and FOLFIRI for colorectal liver metastasis].
    Amano R; Yamada N; Noda E; Kubo N; Tanaka H; Muguruma K; Inoue T; Yashiro M; Maeda K; Onoda N; Sawada T; Nakata B; Ohira M; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2003-5. PubMed ID: 20037305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
    Masi G; Cupini S; Marcucci L; Cerri E; Loupakis F; Allegrini G; Brunetti IM; Pfanner E; Viti M; Goletti O; Filipponi F; Falcone A
    Ann Surg Oncol; 2006 Jan; 13(1):58-65. PubMed ID: 16372158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan-based chemotherapy in a metastatic colorectal cancer patient under haemodialysis for chronic renal dysfunction: two cases considered.
    Vénat-Bouvet L; Saint-Marcoux F; Lagarde C; Peyronnet P; Lebrun-Ly V; Tubiana-Mathieu N
    Anticancer Drugs; 2007 Sep; 18(8):977-80. PubMed ID: 17667606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytoreductive surgery of liver metastasis from colorectal cancer: principles of intra-arterial regional chemotherapy].
    Malinovskiĭ NN; Severtsev AN; Smirnova NB
    Khirurgiia (Mosk); 2003; (3):14-21. PubMed ID: 12698647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients.
    Yumuk PF; Aydin SZ; Dane F; Gumus M; Ekenel M; Aliustaoglu M; Karamanoglu A; Sengoz M; Turhal SN
    Int J Colorectal Dis; 2004 Nov; 19(6):609-10. PubMed ID: 15293062
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.
    Fiorentini G; Aliberti C; Turrisi G; Del Conte A; Rossi S; Benea G; Giovanis P
    In Vivo; 2007; 21(6):1085-91. PubMed ID: 18210761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unresectable hepatic colorectal metastases: need for new surgical strategies.
    Vauthey JN; Abdalla EK
    Ann Surg Oncol; 2006 Jan; 13(1):5-6. PubMed ID: 16372151
    [No Abstract]   [Full Text] [Related]  

  • 20. [Second-line irinotecan chemotherapy in the treatment of metastatic colorectal cancers: phase III trials].
    Mitry E; Ducreux M; Rougier P
    Bull Cancer; 1998 Dec; Spec No():38-42. PubMed ID: 9932083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.